This sequencing strategy revealed lack of CHIP in HGPS patients, whereas it did detect a substantial prevalence of CHIP mutations in healthy middle-aged individuals and elderly HF patients, who can be considered adequate biological aging controls for our cohort of HGPS patients. This evidence concerns the gene STUB1 and Hutchinson-Gilford progeria syndrome.